Please provide your email address to receive an email when new articles are posted on . Physicians who care for patients with advanced cancer hear this question frequently. Predicting the future ...
Using individual patient data from phase 2 and 3 trials, investigators analyzed the value of pathologic complete response vs ctDNA clearance after neoadjuvant immunotherapy or perioperative ...
Given the shortcomings of proteinuria alone for lupus nephritis prognosis, a team is evaluating the Treatment Response Measure for SLE (TRM-SLE), a novel multi-domain clinical outcome assessment tool.
In the article that accompanies this editorial, Gallois et al 12 investigated the added value of transcriptomic signatures incorporating tumoral, stromal, and immune features to refine the prognosis ...
Postoperative detection of circulating EGFR transcripts as a surrogate marker for circulating tumor cells to predict tumor recurrence after adjuvant radio(chemo ...
Radiological markers of treatment response and prognostication in malignant pleural mesothelioma have limitations due to the morphology of the disease. Serum or pleural fluid biomarkers that could act ...
Neurological markers are used to predict outcomes in patients resuscitated after cardiac arrest, and are crucial in informing treatment decisions in comatose patients. A multicenter study reports that ...
There are hundreds, possibly thousands, of different connectors. Which would be the most appropriate for use with the Pedagogical and Phantasmagorical Inamorata Prognostication Engine? There are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results